Creative Peptides
Peptide-based treatment for diabetes mellitus
Therapies based on the GLP-1 are novel treatment options for type 2 diabetes that act through a variety of complementary mechanisms. Unlike other diabetes drugs, the insulinotropic effect of GLP-1 is self-limiting, as it falls once the plasma glucose level is lowered to normal range, reducing the risk of hypoglycemia.
More info, please see: www.creative-peptides.com/research-areas/peptides-in-diab...
Peptide-based treatment for diabetes mellitus
Therapies based on the GLP-1 are novel treatment options for type 2 diabetes that act through a variety of complementary mechanisms. Unlike other diabetes drugs, the insulinotropic effect of GLP-1 is self-limiting, as it falls once the plasma glucose level is lowered to normal range, reducing the risk of hypoglycemia.
More info, please see: www.creative-peptides.com/research-areas/peptides-in-diab...